A randomised open label trial to assess change in respiratory function for people with cystic fibrosis(pwCF) established on triple combination therapy (Kaftrio™) after rationalisation of nebulised mucoactive therapies (the CF STORM trial)

Project Details

StatusActive
Effective start/end date1/02/2131/01/24

Funding

  • National Institute for Health Research: £185,545.00